GUideline adherence and risk assessment after acute myocardiaL infarction in real LIfe in Germany – a quality improVEment and awareness Registry of the German Cardiac Society

GUideline adherence and risk assessment after acute myocardiaL infarction in real LIfe in Germany – a quality improVEment and awareness Registry of the German Cardiac Society - GULLIVE-R

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017164

Enrollment

3000

Registered

2019-05-13

Start date

2019-07-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I21.9

Interventions

Group 1: To assess the use of guideline-adherent secondary prevention therapies and the use of risk assessments in patients in the chronic phase after an acute myocardial infarction in real world in G

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: =18 years Myocardial infarction (NSTEMI or STEMI) 7-15 months before inclusion Written informed consent for participation in observational study Not simultaneously participating in any randomized trial No explicit medical exclusion criteria are stated to avoid selection bias.

Exclusion criteria

Exclusion criteria: No special exclusion criteria

Design outcomes

Primary

Measure	Time frame
GUideline adherence and risk assessment	—

Secondary

Measure	Time frame
Antithrombotic therapy, concomitant diseases, Events during 6-month follow-up after baseline visit	—

Countries

Germany

Contacts

Public ContactMarcel Kunadt

IHF GmbH - Institut für Herzinfarktforschung

kunadt@ihf.de062159577223

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026